Previous Section
Drug Therapy
10. Aripiprazole: pharmacology and evidence in bipolar disorder.
- Author
- McIntyre RS; Soczynska JK; Woldeyohannes HO; Miranda A; Konarski JZ;
- Institution
- Department of Psychiatry, University of Toronto, Toronto, ON, Canada. roger.mcintyre@uhn.on.ca
- Journal
- Expert Opin Pharmacother. 2007 May;8(7):1001-9.
- Abstract URL
- Click here to view abstract
11. The role of mood stabilisers in the treatment of the depressive facet of bipolar disorders.
- Author
- Bourin M; Prica C;
- Institution
- EA 3256 Neurobiologie de l'anxiete et de la depression, Faculte de Medecine 1, rue Gaston Veil BP 53508, 44035 Nantes cedex 01, France.
- Journal
- Neurosci Biobehav Rev. 2007 Mar 15;.
- Abstract URL
- Click here to view abstract
12. Mirtazapine monotherapy versus combination therapy with mirtazapine and aripiprazole in depressed patients without psychotic features: A 4-week open-label parallel-group study.
- Author
- Schule C; Baghai TC; Eser D; Hecht S; Hermisson I; Born C; Hafner S; Nothdurfter C; Rupprecht R;
- Institution
- Department of Psychiatry and Psychotherapy, Ludwig-Maximilian-University. Munich. Germany.
- Journal
- World J Biol Psychiatry. 2007;8(2):112-22.
- Abstract URL
- Click here to view abstract
13. Atypical Antipsychotics for the Treatment of Bipolar Disorder : More Shadows than Lights.
- Author
- Gentile S;
- Institution
- Department of Mental Health, ASL Salerno 1, Mental Health Center n. 4, Cava de' Tirreni, Salerno, Italy.
- Journal
- CNS Drugs. 2007;21(5):367-387.
- Abstract URL
- Click here to view abstract
Next: Clinical Trials
